MHRA publishes ‘world first’ decentralised manufacturing guidance The guidance will inform the manufacture of medicines with a short shelf-life or highly personalised medicines at sites within or in close proximity to hospitals.…
Discussing evidence with patients when prescribing To facilitate shared decision making, prescribers need to guide patients through the risks and benefits of medicine use and be confident to explain the evidence-base underpinning different treatment options.…
NHS pharmacogenomics trial expands to 20 sites across England The PROGRESS trial is planned to finish in early 2026, with an impact assessment produced in the fourth quarter of 2025/2026.…
Genetic testing could prevent three-quarters of avoidable side effects of some medicines, study suggests Researchers found that patients experiencing adverse drug reactions to treatments for psychiatric disorders and cardiovascular problems could benefit the most from personalised prescribing with pharmacogenomics.…
Medication maths: calculations involving molecular weight This article is part of a comprehensive series on pharmaceutical calculations in preparation for the General Pharmaceutical Council registration assessment. It provides guidance on how to tackle questions that involve calculations based on molecular weight, including a worked example of a sample exa…
Only 15% of NHS trusts meet emergency department pharmacy support standards, investigation finds Exclusive: Freedom of information requests showed that only 15 of 98 NHS trusts in England met Royal College of Emergency Medicine and UK Clinical Pharmacy Association recommendations on pharmacy staffing levels.…
Case-based learning: nutrition and feeding considerations for hospitalised neonates When neonates are faced with feeding constraints, it is important that pharmacists work effectively within the multidisciplinary team to improve decision-making and provide effective support for mothers and families.…
Rapid on-site genetic sequencing could help curb antimicrobial-resistant outbreaks, says MHRA Researchers found that rapid on-site genetic sequencing detects bacterial infections within two days, which is “significantly faster“ than traditional methods.…
NICE recommends once-weekly injection for severe blood clotting disorder Efanesoctocog alfa, a once-weekly treatment for patients with severe haemophilia A, removes the need for frequent dosing, owing to its effective bleeding control.…
Nine in ten people would accept a pharmacogenomics test, reveals survey The majority of respondents to a survey said they would be motivated to take a pharmacogenomics test to enhance drug effectiveness and reduce the risk of adverse drug reactions.…
